MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma (2016)
Source: Endocrine - Related Cancer. Unidade: ICB
Subjects: CARCINOMA, NEOPLASIAS, NEOPLASIAS DA TIREOIDE, HORMÔNIOS TIREOIDIANOS
ABNT
ROMITTI, Miriam et al. MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma. Endocrine - Related Cancer, v. 23, n. 3, p. 135-146, 2016Tradução . . Disponível em: http://lattes.cnpq.br/1377108494455149. Acesso em: 06 nov. 2024.APA
Romitti, M., Wajner, S. M., Ceolin, L., Ferreira, C. V., Ribeiro, R. V. P., Rohenkohl, H. C., et al. (2016). MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma. Endocrine - Related Cancer, 23( 3), 135-146. doi:10.1530/ERC-15-0162NLM
Romitti M, Wajner SM, Ceolin L, Ferreira CV, Ribeiro RVP, Rohenkohl HC, Weber S de S, Lopez PL da C, Fuziwara CS, Kimura ET, Maia ALS. MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma [Internet]. Endocrine - Related Cancer. 2016 ; 23( 3): 135-146.[citado 2024 nov. 06 ] Available from: http://lattes.cnpq.br/1377108494455149Vancouver
Romitti M, Wajner SM, Ceolin L, Ferreira CV, Ribeiro RVP, Rohenkohl HC, Weber S de S, Lopez PL da C, Fuziwara CS, Kimura ET, Maia ALS. MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma [Internet]. Endocrine - Related Cancer. 2016 ; 23( 3): 135-146.[citado 2024 nov. 06 ] Available from: http://lattes.cnpq.br/1377108494455149